Given their central role in inflammation and immune response, APPs are potential targets for therapeutic intervention. Modulating the levels of these proteins could help manage inflammatory diseases more effectively. For instance, strategies to inhibit excessive CRP production have been explored in the context of cardiovascular disease. Histological analyses can help evaluate the efficacy and safety of such therapeutic approaches by providing detailed insights into tissue responses.
